The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $8.86

Today's change0.00 0.00%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $8.86

Today's change0.00 0.00%
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.

ImmunoGen Inc closed at (U.S.)$8.86.

Shares have lost 12.19% over the last five days, but have gained 45.25% over the last year to date. This security has underperformed the S&P 500 by 41.67% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $8.86
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+45.25%
  • Volume0
  • Average volume (10-day)1,393,114
  • Average volume (1-month)1,823,536
  • Average volume (3-month)1,677,030
  • 52-week range(U.S.) $5.34 to (U.S.) $13.78
  • Beta1.71
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.85
Updated April 27 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue481367
Total other revenue--------
Total revenue481367
Gross profit--------
Total cost of revenue--------
Total operating expense35353244
Selling / general / administrative7766
Research & development28282638
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income14-22-27-37
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax14-22-26-37
Income after tax14-22-26-37
Income tax, total--000
Net income14-22-26-37
Total adjustments to net income--------
Net income before extra. items14-22-26-37
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14-22-26-37
Inc. avail. to common incl. extra. items14-22-26-37
Diluted net income14-22-26-37
Dilution adjustment----00
Diluted weighted average shares87868686
Diluted EPS excluding extraordinary itemsvalue per share0.16-0.26-0.31-0.44
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.16-0.26-0.31-0.44